---
title: "NP47725a Emicizumab (Indication Specific)"
ocid: "ocds-r6ebe6-0000810514"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000810514"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000810514.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000810514.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2025-10-27"
---

# NP47725a Emicizumab (Indication Specific)

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-r6ebe6-0000810514

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000810514)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000810514.json)

## Summary

The Common Services Agency, also known as NHS National Services Scotland (NSS), has completed the procurement process for the supply of Emicizumab, intended specifically for certain medical indications, under the procurement ID SEP539510. The initiative is overseen from their Edinburgh office. This procurement falls within the health industry category, focusing on goods, specifically pharmaceutical products. The procurement method employed was limited, opting for an award procedure without prior competitive tendering, primarily due to the absence of competition for some medicines, as supported by the relevant public contracts regulations. The contract was signed on 27 August 2025, with Roche Products Ltd being the awarded supplier, headquartered in Welwyn Garden City, UK. The framework encompasses all entities constituted under the National Health Service (Scotland) Act 1978 and relevant Integrated Joint Boards.

This tender presents significant opportunities for businesses within the pharmaceutical industry, particularly those specialising in patented or exclusive medicines that meet specific medical needs. Given its nature as a single-supplier framework agreement valued at approximately £3.12 million, large pharmaceutical companies with a portfolio of protected products, like Roche, are well-suited to leverage such tenders to expand their market within NHS Scotland. Delivering on such contracts not only offers economic benefits but also helps in establishing long-term credibility and partnerships within the healthcare sector.

## Notice

Supply of Emicizumab (Indication Specific) to NHS Scotland.

### Lot Information

Lot 1

The Framework Agreement is for the supply of Emicizumab (Indication Specific) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

### Procurement Information

Competition for some of the medicines awarded to the Framework Agreement is absent for technical reasons, in accordance with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015. Some of the medicines awarded to the Framework Agreement are protected by exclusive rights, including intellectual property rights, in accordance with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT542102 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 27 Oct 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 27 Aug 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £3,120,312 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ROCHE PRODUCTS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 27 Oct 2025 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT542102
- 18 Sep 2025 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP539510

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP539510
  NP47725a Emicizumab (Indication Specific) - Supply of Emicizumab (Indication Specific) to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT542102
  NP47725a Emicizumab (Indication Specific) - Supply of Emicizumab (Indication Specific) to NHS Scotland.

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000810514

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000810514. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000810514.json.